In this study, the authors clarified the AEs and risk factors associated with FN in clinical settings. Non-hematological AEs as well as substantial hematological AEs were recognized in the Japanese population treated with docetaxel chemotherapy against CRPC.

READ FULL ARTICLE Curated publisher From Mdlinx